Form 8K Beyond Air Inc For: 18 August
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Beyond Air Inc (XAIR)
Track today's live Beyond Air (XAIR) share price, performance and key data on this page with our current NASDAQ:XAIR stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Beyond Air share price on the NASDAQ exchange. Use the dropdown to switch exchange for the XAIR share price, head to our technical summary section, which provides analysis on Beyond Air share price buy/sell indicators using real-time data (or discuss the Beyond Air (XAIR) stock price today with other investors in the Beyond Air NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:XAIR share price (ISIN: US08862L3015) to enhance your trading decisions with our free investment tools and resources.
What Is the Beyond Air Inc Share Price Today?
The Beyond Air share price today is 5.210.
What Is the Stock Symbol for Beyond Air Inc
The stock symbol (or 'ticker') for Beyond Air Inc is "XAIR."
What Stock Exchange Does Beyond Air Inc Trade On?
Beyond Air Inc is listed and trades on the NASDAQ stock exchange.
Is Beyond Air Inc a Good Stock to Buy?
Determining whether Beyond Air (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:XAIR share price (ISIN: US08862L3015) to enhance your trading decisions with our free investment tools and resources.
What Is the Beyond Air Inc Share Price Today?
The Beyond Air share price today is 5.210.
What Is the Stock Symbol for Beyond Air Inc
The stock symbol (or 'ticker') for Beyond Air Inc is "XAIR."
What Stock Exchange Does Beyond Air Inc Trade On?
Beyond Air Inc is listed and trades on the NASDAQ stock exchange.
Is Beyond Air Inc a Good Stock to Buy?
Determining whether Beyond Air (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.090
5.950
52 wk Range
5.020
95.600
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.0905.950
52 wk Range
5.02095.600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
XAIR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
30.000
Upside
+475.82%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Form 8K Beyond Air Inc For: 6 August- Investing.com
Top insider buys and sells disclosed on Friday- Investing.com
- Form 8K Beyond Air Inc For: 18 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 30.000
(+475.82% Upside)
Beyond Air Inc SWOT Analysis
Innovative NO Delivery | Beyond Air's LungFit PH system generates nitric oxide from room air, potentially disrupting the $700 million global market for NO delivery systems |
Financial Hurdles | Explore Beyond Air's strategy to overcome significant cash burn and reach cash flow breakeven by fiscal year 2027, despite lowered revenue projections |
Market Expansion Plans | Learn about Beyond Air's efforts to expand LungFit PH's approved uses, including a pending FDA decision for cardiac surgeries and pursuit of CE mark in Europe |
Competitive Landscape | Delve into Beyond Air's positioning against dominant players like Mallinckrodt, with analyst price target at $2.00 amid market challenges and opportunities |
Beyond Air Inc Earnings Call Summary for Q1/2027
- Beyond Air reported Q1 FY2027 revenue of $1.77M, missing estimates of $2.21M by 19.9%; shares fell 7.11% premarket to $5.62.
- Gross margin improved to 13% from 9% YoY, marking third consecutive quarter of positive gross profit; R&D expenses declined 35.5%.
- Company reaffirmed FY2026 revenue guidance of $8M and FY2027 outlook of $16M-$18M, contingent on second-generation LungFit PH FDA approval.
- Management expects FDA decision on next-generation LungFit PH system in Q4 2026; secured $10M financing to fund commercial launch and expansion.
- Net loss widened to $7.9M from $7.7M YoY; commercial pipeline doubled in recent months but execution risks remain amid ongoing cash burn.
Last Updated: 13/08/2026, 14:18
Read Full TranscriptEarnings
Latest Release
13/08/2026
EPS / Forecast
-11.00 / -10.90
Revenue / Forecast
1.77M / 2.21M
Compare XAIR to Peers and Sector
Metrics to compare | XAIR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipXAIRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −1.4x | −0.3x | |
PEG Ratio | 0.00 | −0.06 | 0.00 | |
Price/Book | 1.9x | 3.0x | 2.6x | |
Price / LTM Sales | 0.5x | 2.7x | 3.1x | |
Upside (Analyst Target) | - | 10.8% | 48.5% | |
Fair Value Upside | Unlock | 5.3% | 6.3% | Unlock |
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-high concentration NO (UNO) that is in Phase 1 clinical trial to treat solid tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Beyond Air (NASDAQ: XAIR) Share Price Today?
The Beyond Air stock price today is 5.210 USD.
What Stock Exchange Does Beyond Air (XAIR) Trade On?
Beyond Air is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Beyond Air?
The stock symbol (also called a 'ticker') for Beyond Air is "XAIR."
What Is the Current Beyond Air Market Capitalisation?
As of today, Beyond Air (NASDAQ: XAIR) market cap is 3.750M USD.
What Is Beyond Air's (XAIR) Earnings Per Share (TTM)?
The Beyond Air EPS is currently -62.876 (Trailing Twelve Months).
When Is the Next Beyond Air Earnings Date?
Beyond Air's next earnings report will be released on 16/11/2026.
Is XAIR a Buy or Sell From a Technical Analyst Perspective?
Based on today's Beyond Air moving averages and other technical indicators, the daily buy/sell signal for XAIR stock is Strong Sell.
How Many Times Has Beyond Air Stock Split?
Beyond Air has split 3 times. (See the XAIR stock split history page for full effective split date and price information.)
How Many Employees Does Beyond Air Have?
Beyond Air has 54 employees, based on their latest Companies House report.
What is the current trading status of Beyond Air (NASDAQ: XAIR)?
As of 20/08/2026, Beyond Air (XAIR) is trading at a share price of 5.210 USD, with a previous close of 5.210 USD. The stock has fluctuated within a day range of 5.090 USD to 5.950 USD, while its 52-week range spans from 5.020 USD to 95.600 USD.
What Is Beyond Air (XAIR) Price Target According to Analysts?
The average 12-month price target for Beyond Air is 30.000 USD, with a high estimate of 30 USD and a low estimate of 30 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +475.82% Upside potential.
What Is the XAIR After Hours Price?
XAIR's last after hours stock price is 5.230 USD, the stock has decreased by 0.020, or 0.380%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.